Literature DB >> 16121206

RNA interference against Hec1 inhibits tumor growth in vivo.

E N Gurzov1, M Izquierdo.   

Abstract

Hec1 (highly expressed in cancer) plays an important role in chromosome segregation by interacting with a subset of checkpoint proteins that survey proper chromosome alignment and bipolar spindle attachment. In order to disrupt mitotic progression of tumor cell lines, we have used retrovirus and adenovirus vectors that inhibit Hec1 synthesis. Vector-expressed short hairpin RNAs (shRNAs) caused very efficient depletion of the target protein, cellular arrest and considerable mitotic catastrophe induction 96 h post infection in human cervix-adenocarcinoma (HeLa) and glioblastoma (U-373-MG) cell lines. Furthermore, adenocarcinomas induced in the flanks of nude mice show significant reduction in size compared with control when treated with either Hec1-shRNA retroviruses or adenoviruses. These results indicate that depletion of Hec1 could be used as a new strategy to block the dividing cell, and therefore against cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16121206     DOI: 10.1038/sj.gt.3302595

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  21 in total

Review 1.  RNAi therapeutics: principles, prospects and challenges.

Authors:  Lars Aagaard; John J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

Review 2.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

Review 3.  Targeting mitotic pathways for endocrine-related cancer therapeutics.

Authors:  Shivangi Agarwal; Dileep Varma
Journal:  Endocr Relat Cancer       Date:  2017-06-14       Impact factor: 5.678

4.  Hec1 contributes to mitotic centrosomal microtubule growth for proper spindle assembly through interaction with Hice1.

Authors:  Guikai Wu; Randy Wei; Eric Cheng; Bryan Ngo; Wen-Hwa Lee
Journal:  Mol Biol Cell       Date:  2009-09-23       Impact factor: 4.138

5.  Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.

Authors:  Peng Hu; Jianying Shangguan; Leida Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

6.  Proinvasion metastasis drivers in early-stage melanoma are oncogenes.

Authors:  Kenneth L Scott; Cristina Nogueira; Timothy P Heffernan; Remco van Doorn; Sabin Dhakal; Jason A Hanna; Chengyin Min; Mariela Jaskelioff; Yonghong Xiao; Chang-Jiun Wu; Lisa A Cameron; Samuel R Perry; Rhamy Zeid; Tamar Feinberg; Minjung Kim; George Vande Woude; Scott R Granter; Marcus Bosenberg; Gerald C Chu; Ronald A DePinho; David L Rimm; Lynda Chin
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

7.  Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures.

Authors:  Ho Lun Wong; Zancong Shen; Ze Lu; M Guillaume Wientjes; Jessie L-S Au
Journal:  Mol Pharm       Date:  2011-03-29       Impact factor: 4.939

8.  Small molecule targeting the Hec1/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal.

Authors:  Guikai Wu; Xiao-Long Qiu; Longen Zhou; Jiewen Zhu; Richard Chamberlin; Johnson Lau; Phang-Lang Chen; Wen-Hwa Lee
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

9.  Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines.

Authors:  T Michael Numnum; Sharmila Makhija; Baogen Lu; Minghui Wang; Angel Rivera; Mariam Stoff-Khalili; Ronald D Alvarez; Zeng Bian Zhu; David T Curiel
Journal:  Gynecol Oncol       Date:  2007-12-03       Impact factor: 5.482

Review 10.  Lipid-based systemic delivery of siRNA.

Authors:  Yu-Cheng Tseng; Subho Mozumdar; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2009-03-26       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.